Noticias de investigación
Ver artículos por meses y años
1–4 of 4 artículos
-
Bisphosphonate Prevents Bone Loss During Breast Cancer Therapy (en inglés)
In premenopausal women, chemotherapy to treat early-stage breast cancer can cause the ovaries to shut down, either temporarily or permanently. Because the ovaries produce most of the estrogen in a prem...
-
Bone drug works for breast cancer survivors (en inglés)
A study found that the bone-strengthening medicine Actonel (chemical name: risendronate) can improve bone health after chemotherapy for breast cancer and can minimize the bone weakening that can happen...
-
Bone drug helps fight cancer spread - U.S. report (en inglés)
Zometa (chemical name: zoledronic acid) is a medicine used to strengthen bones in women diagnosed with breast cancer that has spread to the bone. Zometa can reduce bone pain and the risk of fractures. ...
-
Risedronate averts breast cancer-related bone loss (en inglés)
Aggressive breast cancer treatment offers you the hope of living a long, healthy life after treatment. But some breast cancer treatments may speed up bone loss and increase the risk of osteoporosis.
1–4 of 4 artículos
